Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 7Plasma cell 3Other solid neoplasm 2Other hematologic neoplasm 2Tumor-Agnostic 1Sarcoma 1Myeloid 1Gastrointestinal 1Classical hematology 1

Conditions

Sarcoma 1Neoplasm Metastasis 1Carcinoma 1

Interventions

Radiotherapy 221Cyclophosphamide 211Doxorubicin 210Temozolomide 182Ifosfamide 121Filgrastim 111Imatinib Mesylate 104Etoposide 101Vincristine 92Gemcitabine 89Bevacizumab 83Magnetic Resonance Spectroscopy 81Irinotecan 79pembrolizumab 75Radiation 70Carboplatin 65Methotrexate 62pazopanib 61Nivolumab 58Cisplatin 58fludarabine phosphate 57Surgical Procedures, Operative 57Peripheral Blood Stem Cell Transplantation 57Specimen Handling 56Trabectedin 52Docetaxel 50Biopsy 50Busulfan 49Melphalan 46Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
darinaparsin × Sarcoma × Clear all
NCT01139346 2012-07-19

Study of Oral Darinaparsin in Patients With Advanced Solid Tumors

Alaunos Therapeutics

Phase 1 Completed
12 enrolled
Sarcoma

Carcinoma, Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡